Kasagi K, Hatabu H, Miyamoto S, Takeuchi R, Misaki T, Sakahara H, Iida Y, Konishi J
Department of Nuclear Medicine, Kyoto University Hospital, Japan.
Eur J Nucl Med. 1994 Sep;21(9):962-7. doi: 10.1007/BF00238120.
The present study was designed to analyse the scintigraphic appearance of the thyroid in hypothyroid patients with blocking-type TSH receptor antibodies (TRAbs). Eleven hypothyroid patients with autoimmune thyroiditis positive for TSH binding inhibitor immunoglobulins (TBII) [80% +/- 12 (SD)%; normal < 11%] and for thyroid stimulation-blocking antibodies (TSBAbs) (90% +/- 9%: normal < 32%) were studied. Thyroid scanning was performed using technetium-99m or iodine-123, when the patients were hypothyroid. Analysis of the scan images revealed the presence of localized functioning areas in six patients (group 1), and no visualization of the thyroid in the remaining five patients (group 2). Patients in group 1 showed significantly higher uptake of 99mTc than those in group 2 (P < 0.05). Interestingly, three patients in group 1 were positive for thyroid-stimulating antibodies (TSAbs) (249% +/- 17%; normal < 145%), which were not detected in the remaining eight patients. Antibodies against thyroglobulin and microsomal antigens were detected in nine nine (81.8%) and 11 (100%) patients, respectively, but neither of these titres correlated with the scan image. Three patients in group 1 underwent scintigraphy again after treatment with thyroxine, at which time the functioning lesion was not noted. Fourteen hypothyroid patients with negative TBII displayed no such scintigraphic findings. Chronic stimulation of the thyroid by TSAbs and/or TSH might be responsible for the presence of the functioning lesion, but clarification of the mechanism requires further studies. In summary (1) TSAbs were detected in three (27.3%) of 11 hypothyroid patients with blocking TRAbs; (2) thyroid scintigraphy revealed the presence of localized functioning area(s) in approximately half of these cases.
本研究旨在分析伴有阻断型促甲状腺激素受体抗体(TRAbs)的甲状腺功能减退患者甲状腺的闪烁显像表现。对11例甲状腺功能减退且促甲状腺激素结合抑制性免疫球蛋白(TBII)呈阳性[80%±12(标准差)%;正常<11%]以及甲状腺刺激阻断抗体(TSBAbs)呈阳性(90%±9%;正常<32%)的自身免疫性甲状腺炎患者进行了研究。当患者处于甲状腺功能减退状态时,使用锝-99m或碘-123进行甲状腺扫描。对扫描图像的分析显示,6例患者(第1组)存在局部功能区,其余5例患者(第2组)甲状腺未显影。第1组患者的99mTc摄取量显著高于第2组患者(P<0.05)。有趣的是,第1组中有3例患者促甲状腺激素刺激抗体(TSAbs)呈阳性(249%±17%;正常<145%),其余8例患者未检测到。分别在9例(81.8%)和11例(100%)患者中检测到抗甲状腺球蛋白和微粒体抗原的抗体,但这些抗体滴度均与扫描图像无关。第1组中有3例患者在接受甲状腺素治疗后再次进行闪烁显像,此时未发现功能性病变。14例TBII阴性的甲状腺功能减退患者未出现此类闪烁显像结果。TSAbs和/或促甲状腺激素对甲状腺的长期刺激可能是功能性病变存在的原因,但机制的阐明需要进一步研究。总之,(1)在11例伴有阻断型TRAbs的甲状腺功能减退患者中,3例(27.3%)检测到TSAbs;(2)甲状腺闪烁显像显示,约半数此类病例存在局部功能区。